AZD-6482

DB14980InvestigationalSmall molecule

AZD-6482 is under investigation in clinical trial NCT00688714 (Study to Investigate Safety and Tolerability of a Single Dose of AZD6482).

Chemical structure of AZD-6482
Formula / weight
C22H24N4O4 · 408.458 g/mol (avg)
Code names
AZD-6482 · TBO-309

Resolves to

Compound
UNII78G6MP5PZ5CAS1173900-33-8ChEMBLCHEMBL2165191ChEBI91359
Structure
InChIKeyIRTDIKMSKMREGO-OAHLLOKOSA-NSMILESC[C@@H](NC1=CC=CC=C1C(O)=O)C1=CC(C)=CN2C(=O)C=C(N=C12)N1CCOCC1
Targets
P42338PIK3CB

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with AZD-6482, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In